1. Home
  2. NCNA vs YOSH Comparison

NCNA vs YOSH Comparison

Compare NCNA & YOSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCNA
    SELLHOLDBUYas of 18 hours ago
  • YOSH
    SELLHOLDBUYas of 18 hours ago
  • Stock Information
  • Founded
  • NCNA 1997
  • YOSH 2016
  • Country
  • NCNA United Kingdom
  • YOSH United States
  • Employees
  • NCNA N/A
  • YOSH N/A
  • Industry
  • NCNA Biotechnology: Pharmaceutical Preparations
  • YOSH Restaurants
  • Sector
  • NCNA Health Care
  • YOSH Consumer Discretionary
  • Exchange
  • NCNA Nasdaq
  • YOSH Nasdaq
  • Market Cap
  • NCNA 4.5M
  • YOSH 18.8M
  • IPO Year
  • NCNA 2017
  • YOSH 2022
  • Fundamental
  • Price
  • NCNA $0.80
  • YOSH $18.00
  • Analyst Decision
  • NCNA Buy
  • YOSH
  • Analyst Count
  • NCNA 2
  • YOSH 0
  • Target Price
  • NCNA $25.00
  • YOSH N/A
  • AVG Volume (30 Days)
  • NCNA 39.0K
  • YOSH 148.2K
  • Earning Date
  • NCNA 03-19-2025
  • YOSH 03-31-2025
  • Dividend Yield
  • NCNA N/A
  • YOSH N/A
  • EPS Growth
  • NCNA N/A
  • YOSH N/A
  • EPS
  • NCNA N/A
  • YOSH N/A
  • Revenue
  • NCNA N/A
  • YOSH $11,652,880.00
  • Revenue This Year
  • NCNA N/A
  • YOSH N/A
  • Revenue Next Year
  • NCNA N/A
  • YOSH N/A
  • P/E Ratio
  • NCNA N/A
  • YOSH N/A
  • Revenue Growth
  • NCNA N/A
  • YOSH 25.97
  • 52 Week Low
  • NCNA $0.77
  • YOSH $2.71
  • 52 Week High
  • NCNA $10.79
  • YOSH $18.83
  • Technical
  • Relative Strength Index (RSI)
  • NCNA 34.90
  • YOSH 73.78
  • Support Level
  • NCNA $0.79
  • YOSH $12.00
  • Resistance Level
  • NCNA $0.97
  • YOSH $14.90
  • Average True Range (ATR)
  • NCNA 0.08
  • YOSH 2.01
  • MACD
  • NCNA -0.01
  • YOSH 0.56
  • Stochastic Oscillator
  • NCNA 10.71
  • YOSH 93.28

Stock Price Comparison Chart: NCNA vs YOSH

NCNA
YOSH
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025051015202530354045NCNA VS YOSH

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

About YOSH Yoshiharu Global Co.

Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use